B. Chang

发表

Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides

K. Chapman, R. Harrison, C. Esser, 1993 .

3',4'-Dihydroxyl Groups in Luteolin are Important for Its Inhibitory Activities against ADAMTS-4

Jin-Kyoung Kim, K. Jeong, Yangmee Kim, 2012 .

MK386: a potent, selective inhibitor of the human type 1 5α-reductase

H. Bull, K. Ellsworth, G. Harris, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Phosphinic acid inhibitors of matrix metalloproteinases

W. Hagmann, R. Stein, S. Mills, 1996 .

Inhibition of matrix metalloproteinases by P1 substituted N-carboxyalkyl dipeptides

W. Hagmann, K. Chapman, R. Stein, 1996 .

Inhibition of matrix metalloproteinases by N-carboxyalkyl dipeptides: Enhanced potency and selectivity with substituted P1′ homophenylalanines

M. Maccoss, W. Hagmann, K. Chapman, 1995 .

Mechanistic studies on the human matrix metalloproteinase stromelysin.

R. Stein, R. Harrison, L. Niedzwiecki, 1992, Biochemistry.

4,7 beta-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5 alpha-reductase.

H. Bull, K. Ellsworth, G. Harris, 1994, Journal of medicinal chemistry.

4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.

K. Ellsworth, G. Harris, R. Mosley, 1995, Journal of medicinal chemistry.

Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.

K. Chapman, P L Durette, I E Kopka, 1995, Journal of medicinal chemistry.